Acute Myocardial InfarctionPhase 3NCT00091637
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
A Phase 3 study testing Pexelizumab in people with Acute Myocardial Infarction, run by Procter and Gamble at 349 sites in 17 countries.
Trial summary
In the setting of reperfusion therapy in an acute myocardial infarction using primary percutaneous intervention (PCI), the body's own inflammatory system involving the complement cascade may be harmful. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Acute Myocardial Infarction
- What is being tested?
- Pexelizumab
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 5,745 participants
- Where
- 349 sitesin 17 countries
- Study dates
- Apr 2004to May 2007
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Cardiac symptoms for at least 20 minutes within past 6 hours;
- Will undergo primary PCI;
- Has ECG evidence of acute high risk ST elevation myocardial infarction;
- Willing and able to be followed for at least 12 months.
Who cannot join
- Isolated low risk inferior wall myocardial infarction;
- Received fibrinolytic therapy;
- History of complement deficiency;
- Suspected neisserial infection;
- Participating in other investigational study;
- Pregnancy;
- Previous enrollment.
Trial locations and contacts
349 sites in 17 countries.
349 sites in 17 countries
United States180 sites
Akron General Medical Center
Akron, Ohio, 44307
Albany Medical Center
Albany, New York, 12211
New Mexico Heart Institute
Albuquerque, New Mexico, 87102
Inova Alexandria Hospital
Alexandria, Virginia, 22306
Lehigh Valley Hospital
Allentown, Pennsylvania, 18105
Northwest Texas Healthcare System
Amarillo, Texas, 79106
JFK Medical Center
Atlantis, Florida, 33462
Seton Medical Center
Austin, Texas, 78705
Eastern Maine Medical Center
Bangor, Maine, 04401
Highland Park Hospital
Bannockburn, Illinois, 60015
Overtake Hospital Medical Center
Bellevue, Washington, 98004
St. Charles Medical Center
Bend, Oregon, 97701
Brotman Medical Center
Beverly Hills, California, 90230
Deaconess Billings Clinic
Billings, Montana, 59101
St. Luke's Regional Medical Center
Boise, Idaho, 63704
St. Vincent Medical Center
Bridgeport, Connecticut, 06606
Maimonides Medical Center
Brooklyn, New York, 11219
Providence Saint Joseph Medical Center
Burbank, California, 91505
Lousiana Heart Center
Chalmette, Louisiana, 70043
Presbyterian Hospital
Charlotte, North Carolina, 28204
Universitiy of Virginia Health Science Center
Charlottesville, Virginia, 22908
VAMC Cincinnati
Cincinnati, Ohio, 45220
Bethesda North Hospital
Cincinnati, Ohio, 45242
The University Hospital
Cincinnati, Ohio, 45267
Morton Plant Hospital
Clearwater, Florida, 33756
University Hospitals of Cleveland
Cleveland, Ohio, 44103
Cleveland Clinic Foundation
Cleveland, Ohio, 44195
University of Missouri Health Sciences Center
Columbia, Missouri, 65212
Palmetto Richland Memorial Hospital
Columbia, South Carolina, 29203
Sisters of Charity Providence Hospitals
Columbia, South Carolina, 29204
MidWest Cardiology Research Foundation
Columbus, Ohio, 43214
Mercy Hospital
Coon Rapids, Minnesota, 55433
Presbyterian Hospital of Dallas
Dallas, Texas, 57231
Medical City Dallas
Dallas, Texas, 75230
Dallas Medical Center
Dallas, Texas, 75390
Parkland Health & Hospital System
Dallas, Texas, 75390
Geisinger Medical Center
Danville, Pennsylvania, 17822-2160
Genesis Medical Center
Davenport, Pennsylvania, 58803
Oakwood Hospital and Medical Center
Dearborn, Michigan, 48123
University of Colorado Hospital
Denver, Colorado, 80262
Iowa Heart
Des Moines, Iowa, 50314
Henry Ford Hospital
Detroit, Michigan, 48202
Sinai-Grace Hospital
Detroit, Michigan, 48235
St. Mary's Duluth Clinic Health System
Duluth, Minnesota, 55805
Duke University Health Systems
Durham, North Carolina, 27705
Fairview Southdale Hospital
Edina, Minnesota, 55435
Trinitas Hospital
Elizabeth, New Jersey, 07202
Hamot Medical Center
Erie, Pennsylvania, 16550
Palomar Medical Center
Escondido, California, 92025
St. Joseph's Regional Medical Center
Fair Lawn, New Jersey, 07410
University of Connecticut Health Center
Farmington, Connecticut, 06030-2202
North Ridge Medical Center
Fort Lauderdale, Florida, 33308
Brooke Army Medical Center
Fort Sam Houston, Texas, 78234
Sparks Regional Medical Center
Fort Smith, Arkansas, 72901
Spectrum Health
Grand Rapids, Michigan, 49503
Moses Cone Hospital/LeBauer Healthcare
Greensboro, North Carolina, 27401
Pitt County Memorial Hospital
Greenville, North Carolina, 27834
Rockingham Memorial Hospital
Harrisonburg, Virginia, 22801
Ingalls Hospital
Harvey, Illinois, 80426
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033
High Point Regional Health System
High Point, North Carolina, 27262
Ben Taub General Hospital
Houston, Texas, 77030
Memorial Hermann Hospital
Houston, Texas, 77030
Michael E. DeBakey VA Medical Center
Houston, Texas, 77030
Houston Northwest Medical Center
Houston, Texas, 77090
Huntsville Hospital
Huntsville, Alabama, 35801
Methodist Hospital
Indianapolis, Indiana, 46202
VAMC
Indianapolis, Indiana, 46202
Community Hospital South
Indianapolis, Indiana, 46227
The Indiana Heart Hospital
Indianapolis, Indiana, 56250
Jackson-Madison County General Hospital
Jackson, Tennessee, 38301
St. Luke's Hospital
Jacksonville, Florida, 32224
Wilson Memorial Medical Center
Johnson City, New York, 13790
Borgess Medical Center
Kalamazoo, Michigan, 49048
Wellmont Holston Valley Medical Center
Kingsport, Tennessee, 37660
Fort Sanders Rgional Medical Center
Knoxville, Tennessee, 37916
Baptist Hospital of East Tennessee
Knoxville, Tennessee, 37920
Franciscan Skemp Healthcare
La Crosse, Wisconsin, 54601
Lousiana Heart Hospital
Lacombe, Louisiana, 70445
Lancaster General Hospital
Lancaster, Pennsylvania, 17604
Sunrise Hospital
Las Vegas, Nevada, 89109
Central Baptist Hospital
Lexington, Kentucky, 40503
University of Kentucky
Lexington, Kentucky, 40536-0200
St. Elizabeth Medical Center
Lincoln, Nebraska, 68510
Arkansas State Hospital
Little Rock, Arkansas, 72211
Advocate Good Samaritan
Lombard, Illinois, 60148
Elmhurst Hospital
Lombard, Illinois, 60148
Los Angeles Community Hospital
Los Angeles, California, 90033
The Jewish Hospital
Louisville, Kentucky, 40202
Baptist Hospital East
Louisville, Kentucky, 40207
Covenant Medical Center
Lubbock, Texas, 79410
Lynchburg General Hospital
Lynchburg, Virginia, 24501
Med Central Mansfield
Mansfield, Ohio, 44906
Health First Holmes Regional Medical Center
Melbourne, Florida, 32001
Midwest Regional Medical Center
Midwest City, Oklahoma, 73110
Froedtert Hospital
Milwaukee, Wisconsin, 53226
Winthrop University Hospital
Mineola, New York, 11504
Abbott Northwestern Hospital
Minneapolis, Minnesota, 55407
North Memorial Medical Center
Minneapolis, Minnesota, 55422
Trinity Hospital
Minot, North Dakota, 58701
Memorial Medical Center
Modesto, California, 48201
Trinity Medical Center
Moline, Illinois, 61265
West Virginia University Hospital
Morgantown, West Virginia, 26506-9157
Skagit Valley Hospital
Mount Vernon, Washington, 98274
Munster Community Hospital
Munster, Indiana, 46321
Cottonwood Hospital
Murray, Utah, 84107
Mercy General Health Partners
Muskegon, Michigan, 49444
Centennial Medical Center
Nashville, Tennessee, 37203
Yale - New Haven
New Haven, Connecticut, 06520
MCLNO at New Orleans University Campus
New Orleans, Louisiana, 70112
Tulane University Hospital and Clinic
New Orleans, Louisiana, 70112
St. Vincent's Catholic Medical Center
New York, New York, 10011
Bellevue Hospital Center
New York, New York, 10016
Methodist Medical Center
Oak Ridge, Tennessee, 37830
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104
VA Medical Center
Oklahoma City, Oklahoma, 73104
Integris Baptist Medical Center, Inc.
Oklahoma City, Oklahoma, 73112
Oklahoma Heart Hospital
Oklahoma City, Oklahoma, 73120
Florida Heart Hospital
Orlando, Florida, 32803
Saint Francis Medical Center
Peoria, Illinois, 61603
Northern Michigan Hospital
Petoskey, Michigan, 49770
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
Temple University Hospital
Philadelphia, Pennsylvania, 19140
Mayo Clinic Hospital
Phoenix, Arizona, 85054
North Phoenix Heart Center
Phoenix, Arizona
Jefferson Regional Medical Center
Pittsburgh, Pennsylvania, 15025
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212
Western Pennsylvania Hospital
Pittsburgh, Pennsylvania, 15215
VA Pittsburgh Healthcare System
Pittsburgh, Pennsylvania, 15240
St. Joseph Mercy-Oakland
Pontiac, Michigan, 48341-2982
Maine Medical Center
Portland, Maine, 04102
Providence Portland Medical Center
Portland, Oregon, 97213
Vassar Brothers Medical Center
Poughkeepsie, New York, 12601
Rhode Island Hospital
Providence, Rhode Island, 02903
Rapid City Regional Hospital
Rapid City, South Dakota, 57719
Herrico Doctors' Hospital - Forest
Richmond, Virginia
Saint Mary Hospital
Rochester, Minnesota, 55902
Rochester General Hospital
Rochester, New York, 14621
Trinity Medical Center
Rock Island, Illinois, 61201
William Beaumont Hospital
Royal Oak, Michigan, 48073
Sutter Memorial Hospital
Sacramento, California, 95825
Covenant Medical Center
Saginaw, Michigan, 48601
Saint Mary Medical Center
Saginaw, Michigan, 48601
St. Cloud Hospital
Saint Cloud, Minnesota, 56303
Methodist Hospital
Saint Louis Park, Minnesota, 55426
Health East St. Joseph Hospital
Saint Paul, Minnesota, 55102
Northeast Baptist Hospital
San Antonio, Texas, 78217
South Texas Veterans Health Care System Audie L. Murphy Division
San Antonio, Texas, 78258
University of CA, San Diego Medical
San Diego, California, 92103-8784
Sutter Medical Center of Santa Rosa
Santa Rosa, California, 95403
Sarasota Memorial Hospital
Sarasota, Florida, 34239
Harborview Medical Center
Seattle, Washington, 98104
Heart Hospital of South Dakota
Sioux Falls, South Dakota, 57108
Providence Hospital
Southfield, Michigan, 48075
St. John's Hospital
Springfield, Missouri, 65807
St. Louis University Hospital
St Louis, Missouri, 63110
Barnes St. Peters Hospital
St Louis, Missouri, 63122
SUNY - Upstate Medical University
Syracuse, New York, 13210
MultiCare Medical Center (Tacoma General Hospital)
Tacoma, Washington, 98405
St. Joseph Medical Center
Tacoma, Washington, 98405
University Community Hospital
Tampa, Florida, 33613
Scott & White Memorial Hospital
Temple, Texas, 76508
Monteflore Medical Center
The Bronx, New York, 10467
St. Joseph Medical Center
Towson, Maryland, 21204
William Beaumont Hospital
Troy, Michigan, 48085
Northwest Medical Center
Tucson, Arizona, 85741
East Texas Medical Center
Tyler, Texas, 75701
Trinity Mother Frances Hospital
Tyler, Texas, 75701
Providence Holy Cross Medical Center
Valencia, California, 91355
Citizens Medical Center
Victoria, Texas, 77901
Detar Hospital
Victoria, Texas, 77901
Sentara Virginia Beach General Hospital
Virginia Beach, Virginia, 23454
Harper University Hospital
Warren, Michigan, 48201
George Washington University Hospital
Washington D.C., District of Columbia, 20037
Waukesha Memorial Hospital
Waukesha, Wisconsin, 53188
The Chester County Hospital
West Chester, Pennsylvania, 19380
Via Christi Reginal Medical Center
Wichita, Kansas, 67214
Winchester Medical Center
Winchester, Virginia, 22601
York Hospital
York, Pennsylvania, 17405
Genesis Healthcare System
Zanesville, Ohio, 43701
Germany23 sites
Klinikum Augsburg, Stenglinstr. 2.
Augsburg, Bavaria, 86156
Kerckhoff-Klinik Bad Anuheim
Bad Nauheim, Hesse, 61231
Universitatsklinik der Ruhr-Universitat Bochum
Bad Oeynhausen, 32545
Herzzentrum
Bad Segeberg, Schleswig-Holstein, 23795
Vivantes Klinikkum im Friedrichshain
Berlin, 10249
Vivantes Klinikum am Urban
Berlin, 10967
Allgemeines Krankenhaus Celle
Celle, Lower Saxony, 29223
Klinikum Coburg
Coburg, Bavaria, 96450
Kliniken der Stadt Koln
Cologne, North Rhine-Westphalia, 51109
Klinikkum Lippe
Detmold, North Rhine-Westphalia, 32756
St. Johannes Krankenhaus
Dortmund, Nordhein Westfalen, 44137
Herzzentrum Duisburg
Duisburg, Nordhein Westfalen, 47137
Herzzentrum Gottingen
Göttingen, Lower Saxony, 37075
Allgemeines Krankenhaus St. Georg
Hamburg, 20099
Universitatsklinikum Hamburg-Eppendorf
Hamburg, 20246
Klinik fur Innere Medizin 1
Jena, Thuringia, 07740
Stadt. Kliniken Kassel
Kassel, Hesse, 34125
Herz-Zentrum Bad Krozingen
Krozingen, Wurrtemberg, 79189
Universitatsklinik Lubeck
Lübeck, Schleswig-Holstein, 23538
Klinikkum Ludwigshafen
Ludwigshafen am Rhein, Rhineland-Palatinate, 67063
Universitatsklinikum Mannheim
Mannheim, Baden-Wurttemberg, 66167
Stadt Krankenhaus Muenchen-Bogenhausen
München, Bavaria, 81925
Helios Klinikum Wuppertal GmbH
Wuppertal, North Rhine-Westphalia, 42117
Australia21 sites
Royal Adelaide Hospital
Adelaide, South Australia, 5000
Flinders Medical Centre
Bedford Park, South Australia, 5042
Austin Hospital
Box Hill, Victoria, 3084
Box Hill Hospital
Box Hill, Victoria, 3128
Prince Charles Hospital
Chermside, Queensland, 4032
Monash Medical Centre
Clayton, Victoria, 3162
Concord Hospital
Concord, New South Wales, 2137
Townsville Hospital
Douglas, Queensland, 4814
Fremantle Hospital
Fremantle, Western Australia, 6160
Canberra Hospital
Garran, Australian Capital Territory, 2605
Gosford Hospital
Gosford, New South Wales, 2250
St. George Hospital
Kogarah, New South Wales, 2217
Liverpool Hospital
Liverpool, New South Wales, 2170
Sir Charles Gairdner Hospital
Nedlands, Western Australia, 6009
Royal Melbourne Hospital
Parkville, Victoria, 3050
Royal Perth Hospital
Perth, Western Australia, 6000
Prince of Wales Hospital
Randwick, New South Wales, 2031
Victorian Heart Clinic
Richmond, Victoria, 3121
Royal North Shore Hospital
St Leonards, New South Wales, 2065
The Queen Elizabeth Hospital
Woodville South, South Australia, 5011
Princess Alexandra Hospital
Wooloong Abba, Queensland, 4102
Czechia18 sites
Interni kardiologicka klinika, Fakultni nemocnice Brno
Brno, 625 00
I. interni kardioangiologicka klinika, Fakultni nemocnice u Sv. Anny
Brno, 656 91
Kardiologicke odd. Nemocnice Ceske Budejovice as
Caske Budejovice, Ceske Budejovice, 370 878
I. Interni klinika, Fakultni nemocnice Hradec
Kradec Kralove, Hradec Kralove, 500 05
Kardiologicke oddeleni, Masarykova nemocnice
Labem, Usti Nad Labem, 401 13
Kardiologicke odd., Krajska neocnice Liberec
Liberec, 460 63
I. Interni klinika, FN Olomouc
Olomouc, 775-20
Interni klinika, FNsP Ostrava
Ostrava, 708 52
Kardio-Troll sro and Krajska nemocnice Pardubice
Pardubice, 532 03
Kardio-Troll sro and Krajska nemocnice Pardubice
Pardubice, 53203
I. Interni klinika, Fakultni nemocnice Plzen
Pilsen, 304 60
Klinika kardiologie, IKEM
Prague, Prague, 14021
Kardiocentrum, Fakultni nemocnice Kralovske Vinohrady
Prague, 10034
II. Interni klinika, Vseobecna fakultni nemocnice
Prague, 128 08
Kardiologicke odd., Nemocnice Na Homoice
Prague, 150 30
Kardiologicka klinika FN v Motole
Prague, 15006
Kardiocentrum, Nemocnice Podlesi sro
Třinec, 739 61
Interni klinika, Batova nemocnice
Zlín, 462 75
Italy17 sites
A.O. SS. Antonio e Biagio e Cesare Arrigo
Alessandria, 15100
Policlinico Sant'Orsola-Malpighi
Bologna, 40128
Ospedale Centrale di Bolzano
Bolzano, 39100
A.O. Spedali di Civili
Brescia, 25123
Presidio Ospedaliero di Cittadella
Cittadella, Padova, 35013
A.O. della Regione Lombardia Presidio Ospedaliero Sant'Anna
Como, 22100
Ospedale Alessandro Manzoni
Lecco, 23900
Azienda Ospedaliera Carlo Poma
Mantua, 46100
Azienda Ospedaliera di Parma - Ospedale Maggiore
Parma, 43100
Policlinico San Matteo - I.R.C.C.S.
Pavia, 27100
A. O. S. Salvatore
Pesaro, 46100
U.O. Cardiologia
Reggio Emilia, Reggio Emilla, 42100
Osepdale degli Intermi
Rimni, Rimni, 47900
AO S. Camillo Forlanini
Roma, 00152
Centro E Malan
San Donato Milanese, Milano, 20097
Cardiologia Universitaria
Torino, 10126
Ospedale S. Maria di Ca'Foncello
Treviso, 31100
Canada16 sites
Foothills Medical Centre
Calgary, Alberta, T2N 2W8
University of Alberta Hospital
Edmonton, Alberta, T6G 2B7
Hamilton General Hospital
Hamilton, Ontario, L8L 2X2
Trillium Health Center
Mississauga, Ontario, L58 2P7
Montreal Heart Institute/Research Centre
Montreal, Quebec, H1T 1C8
Centre Hospitale de'Universite de Montreal (Pav Notre-Dame)_
Montreal, Quebec, H2L 4M1
Hopital Sacre-Coeur de Montreal
Montreal, Quebec, H4J 1C5
Regina General Hospital
Regina, Saskatchewan, S4P 0W5
Saint John Regional Hospital - New Brunswick Heart Centre
Saint John, New Brunswick, E2L 4L2
Quebec Heart Institute/Laval Hospital
Sainte-Foy, Quebec, G1V 4G5
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, J1H 5N4
General Hospital Health Sciences Centre
St. John's, Newfoundland and Labrador, A1B 3E4
Sunnybrook & Women's Health Sciences Centre
Toronto, Ontario, M4N 3M5
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1L8
St. Paul's Hospital
Vancouver, British Columbia, V6Z 1Y6
Royal Jubilee Hospital
Victoria, British Columbia, V8R 4R2
France15 sites
CHRU de Angers
Angers, 49100
Clinique Saint Joseph
Colmar, 66027
Cardiologie Hopital Simone Veil
Eaubonne-Montmorency, 95601
Centre Hospitalier de Haguenau
Haguenau, 67504
CHRU de Nantes
Nantes, 44000
Hopital Lariboisiere
Paris, 75010
Hopital Bichat
Paris, 75018
Hopital a Pitie Salpetriere
Paris, 75743
Hopital du Haut Leveque
Pessac, 33604
Hopital Pontchaillou
Rennes, 35000
CHRU de Rouen
Rouen, 76000
Centre Cardiologique du Nord
Saint-Denis, 93200
CHRU Hautepierre
Strasbourg, 67100
Hopital Rangueil
Toulouse, 31059
Hopital d'adultes de Brabois (CHU de Nancy)
Vandœuvre-lès-Nancy, 54511
Spain11 sites
Hospital General Universitario de Alicante
Alicante, 03010
Hospital Clinic i Provincial
Barcelona, 08036
Hospital Virgen da la Arrixaca
El Palmar, Murcia, 30120
Ciutat Sanitaria i Universitaria de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907
Hospital de Leon
León, 24008
Hospital General Universitario Gregorio Maranon
Madrid, 28007
Hospital Puerta de Hierro
Madrid, 28035
Hospital Clinico San Carlos
Madrid, 28040
Hospital Clinico Universitario Virgen de la Victoria
Málaga, 29010
Hospital de Navarra
Pamplona, Navarre, 31008
Hopspital Virgen del Rocio
Seville, 41013
Netherlands10 sites
Medeisch Centrum Alkmaar
Alkmaar, North Holland, 1800 AM
VUMC
Amsterdam, North Holland, 1081 HV
OLVG
Amsterdam, North Holland, 1091 HD
Catharina Hospital
Eindhovenb, BR, 5623 EJ
Academic Hospital Maastricht
Maastricht, LI, 6229 HX
Sint Antonius Hospital
Nieuwegein, Utrecht, 3435 CM
Erasmus Medical Centre
Rotterdam, South Holland, 3015 GD
Medisch Centrum Rijnmond-Zuid
Rotterdam, South Holland, 3075 EA
University Medical Center Utrecht
Ultrecht, Utrecht, 3584 CX
Isla Klinieken Location De Weezenlanden
Zwolle, Overijssel, 8011 JW
Portugal8 sites
Hospital Garcia de Orta - Servico de Cardiologia
Almada, Lisbon District, 2801-951 Almada
H. Fernando da Fonesca
Amadora, 3700-376 Amadora
Hospital Santa Cruz
Carnaxide, Lisbon District, 270-134
Hospitals da Universidade de Coimbra
Coimbra, 3000-075 Coimbra
Hospital Curry Cabral
Lisbon, 1069-166 Lisboa
H. Santa Maria
Lisbon, 1600-190 LISBOA
Hospital Sao Joao - Servico de Cardiologia
Porto, 4200-319 Porto
Centro Hospitalar de Vila Nova de Gala
Vila Nova de Gala, 4434-502 Vila Nova de Gala
Belgium5 sites
AZ Middelheim
Antwerp, 2020
ZOL Campus Sint-Jan
Genk, Limburg, 3600
U.Z. Gasthuisberg
Leuven, Brabant, 3000
CHR de la Citadelle
Liège, 4000
Helig Hartziekenhuis
Roeselare, Flanders, 8800
Denmark5 sites
Aalborg Sygehus
Aalborg, Danmark, 9100
Skejby Sygehus
Aarhus, Danmark, 8200
Rigshospitalet
Copenhagen, Danmark, DK-2100
Amtssygehuset i Gentofte
Hellerup, Danmark, 2900
Odense Universitets Hospital
Odense, 5000
New Zealand5 sites
Auckland City Hospital
Auckland, 1003
Christchurch Hospital
Christchurch, Canterbury, 8001
Dunedin Hospital
Dunedin, Otago, 9001
Waikato Hospital
Hamilton, Waikoto, 2001
Wellington Hospital
Wellington, 6002
Poland5 sites
I Klinika Kardiologii
Katowice - Ochojec, 40-635
Klinika Chorob Serca i Naczyn
Krakow, 31-202
II Katedra i Klinika Kardiologii
Lodz, 91-347
I Klinika Choroby Wiencowej
Warsaw, 04-628
SPZOZ Dolnoslaski Szpital Specjalistyczny
Wroclaw, 50-420
Switzerland5 sites
Kantonsspital Basel
Bassel, Bassel, 4031
University Hospital of Geneva
Geneva, Canton of Geneva, CH-1211
Herzklinik Bodensee am Weinberg AG
Kreuzlingen, Thurgau, 8280
Cardiocentro Ticino
Lugano, Canton Ticino, 6900
Kantonsspital St. Gallen
Sankt Gallen, Canton of St. Gallen, CH-9007
Austria3 sites
Krankenhaus der Barmherzigen Schwestern
Linz, 4010
Univ. Klinik f. Innere Medizin II
Vienna, 1090
Wilhelminenspital
Vienna, 1171
Sweden2 sites
Universitetetssjukhuset Umea
Umeå, SE-901-85
Uppsala University Hospital
Uppsala
About this study
Official title: APEX-AMI - Pexelizumab in Conjunction With Angioplasty
In the setting of reperfusion therapy in an acute myocardial infarction using primary percutaneous intervention (PCI), the body's own inflammatory system involving the complement cascade may be harmful. This study will test the safety and efficacy of a novel complement inhibitor, pexelizumab to reduce mortality at 30 days.
- Conditions
- Acute Myocardial Infarction
- Being tested
- Pexelizumab, Placebo infusion
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PexelizumabDrug
Pexelizumab (2 mg/kg) intravenous , bolus for 10 minutes once
Placebo infusionDrug
bolus infusion over a 10 minute period once
| Study group | Role | What they receive |
|---|---|---|
| 1 | Placebo comparator | Placebo infusion Receives: Drug: Placebo infusion |
| 2 | Experimental | Pexelizumab infusion Receives: Drug: Pexelizumab |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reduction of all causes of mortality
Measured: day 30
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2004 (estimated)
- Study startApr 2004
- Primary completionMay 2007
- Study completionMay 2007
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (16)Papers the sponsor has linked to this study.
- Other trials for Acute Myocardial InfarctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 5,745 participants (actual)
Sponsor and investigators
- Lead sponsor
- Procter and Gamble
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Thomas G Todaro, MD, JD, FACC, Study director, Procter and Gamble
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00091637
- Sponsor's protocol ID
- 2003056
- Status last verified
- Nov 2023
- First submitted
- 14 Sep 2004
- Last updated
- 18 Nov 2023
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Bagai A, Armstrong PW, Stebbins A, Mahaffey KW, Hochman JS, Weaver WD, Patel MR, Granger CB, Lopes RD. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study. Am Heart J. 2013 Nov;166(5):913-9. doi: 10.1016/j.ahj.2013.08.006. Epub 2013 Sep 24.
PubMed 24176448Guptill JT, Mehta RH, Armstrong PW, Horton J, Laskowitz D, James S, Granger CB, Lopes RD. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes. Circ Cardiovasc Interv. 2013 Apr;6(2):176-83. doi: 10.1161/CIRCINTERVENTIONS.112.000159. Epub 2013 Apr 2.
PubMed 23549644Westerhout CM, Pieper KS, James SK, Mahaffey KW, de Werf FV, Califf RM, Granger CB, Armstrong PW. Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Am Heart J. 2013 Mar;165(3):354-62.e2. doi: 10.1016/j.ahj.2012.12.001. Epub 2013 Jan 15.
PubMed 23453104Patel MR, Westerhout CM, Granger CB, Brener SJ, Fu Y, Siha H, Kim RJ, Armstrong PW. Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J. 2013 Feb;165(2):226-33. doi: 10.1016/j.ahj.2012.10.028. Epub 2012 Nov 24.
PubMed 23351826Truffa AA, Granger CB, White KR, Newby LK, Mehta RH, Hochman JS, Patel MR, Pieper KS, Al-Khalidi HR, Armstrong PW, Lopes RD. Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes. JACC Cardiovasc Interv. 2012 Jul;5(7):769-76. doi: 10.1016/j.jcin.2012.03.018.
PubMed 22814783Martel C, Granger CB, Ghitescu M, Stebbins A, Fortier A, Armstrong PW, Bonnefoy A, Theroux P. Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J. 2012 Jul;164(1):43-51. doi: 10.1016/j.ahj.2012.04.007. Epub 2012 Jun 15.
PubMed 22795281van Diepen S, Widimsky P, Lopes RD, White KR, Weaver WD, Van de Werf F, Ardissino D, van't Hof AW, Armstrong PW, Granger CB. Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights. Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):437-44. doi: 10.1161/CIRCOUTCOMES.112.965160. Epub 2012 May 15.
PubMed 22589297Hudson MP, Armstrong PW, O'Neil WW, Stebbins AL, Weaver WD, Widimsky P, Aylward PE, Ruzyllo W, Holmes D, Mahaffey KW, Granger CB. Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):183-92. doi: 10.1161/CIRCOUTCOMES.110.945311. Epub 2011 Feb 8.
PubMed 21304097Huber K, Holmes DR Jr, van 't Hof AW, Montalescot G, Aylward PE, Betriu GA, Widimsky P, Westerhout CM, Granger CB, Armstrong PW. Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. Eur Heart J. 2010 Jul;31(14):1708-16. doi: 10.1093/eurheartj/ehq143. Epub 2010 May 25.
PubMed 20501476Alhadramy O, Westerhout CM, Brener SJ, Granger CB, Armstrong PW; APEX AMI Investigators. Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J. 2010 May;159(5):899-904. doi: 10.1016/j.ahj.2010.02.028.
PubMed 20435202Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. JACC Cardiovasc Imaging. 2010 Jan;3(1):52-60. doi: 10.1016/j.jcmg.2009.09.014. Epub 2010 Jan 12.
PubMed 20129531Trendelenburg M, Theroux P, Stebbins A, Granger C, Armstrong P, Pfisterer M. Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J. 2010 May;31(10):1181-7. doi: 10.1093/eurheartj/ehp597. Epub 2010 Jan 19.
PubMed 20089518Brener SJ, Westerhout CM, Fu Y, Todaro TG, Moliterno DJ, Wagner GS, Granger CB, Armstrong PW; APEX-AMI Investigators. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. Am Heart J. 2009 Nov;158(5):755-60. doi: 10.1016/j.ahj.2009.09.009. Epub 2009 Oct 3.
PubMed 19853693Armstrong PW, Fu Y, Westerhout CM, Hudson MP, Mahaffey KW, White HD, Todaro TG, Adams PX, Aylward PE, Granger CB. Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2009 Apr 28;53(17):1503-9. doi: 10.1016/j.jacc.2009.01.046.
PubMed 19389560Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation. 2008 Sep 23;118(13):1335-46. doi: 10.1161/CIRCULATIONAHA.108.767772. Epub 2008 Sep 8.
PubMed 18779444
Study at a glance
From the registry record, last updated by the sponsor on 18 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- APEX-AMI - Pexelizumab in Conjunction With Angioplasty
- ClinicalTrials.gov ID
- NCT00091637
- Acronym / sponsor ID
- 2003056
- Conditions
- Acute Myocardial Infarction
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 5,745 participants (actual)
- Lead sponsor
- Procter and GambleIndustry (pharma, biotech, devices)
- Study start
- Apr 2004
- Primary completion
- May 2007 (actual)
- Study completion
- May 2007 (actual)
- First posted
- 16 Sep 2004 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In the setting of reperfusion therapy in an acute myocardial infarction using primary percutaneous intervention (PCI), the body's own inflammatory system involving the complement cascade may be harmful. This study will test the safety and efficacy of a novel complement inhibitor, pexelizumab to reduce mortality at 30 days.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 1 | Placebo comparator | Drug: Placebo infusionPlacebo infusion |
| 2 | Experimental | Drug: PexelizumabPexelizumab infusion |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Cardiac symptoms for at least 20 minutes within past 6 hours;
- Will undergo primary PCI;
- Has ECG evidence of acute high risk ST elevation myocardial infarction;
- Willing and able to be followed for at least 12 months.
Key exclusion criteria (7 listed)
- Isolated low risk inferior wall myocardial infarction;
- Received fibrinolytic therapy;
- History of complement deficiency;
- Suspected neisserial infection;
- Participating in other investigational study;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PexelizumabPexelizumab (2 mg/kg) intravenous , bolus for 10 minutes once | Drug | 2 |
| Placebo infusionbolus infusion over a 10 minute period once | Drug | 1 |
Primary outcome
Reduction of all causes of mortality
Time frame: day 30
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Nov 2023.
- Derived from this study: PubMed 24176448Bagai A, Armstrong PW, Stebbins A, Mahaffey KW, Hochman JS, Weaver WD, Patel MR, Granger CB, Lopes RD. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study. Am Heart J. 2013 Nov;166(5):913-9. doi: 10.1016/j.ahj.2013.08.006. Epub 2013 Sep 24.
- Derived from this study: PubMed 23549644Guptill JT, Mehta RH, Armstrong PW, Horton J, Laskowitz D, James S, Granger CB, Lopes RD. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes. Circ Cardiovasc Interv. 2013 Apr;6(2):176-83. doi: 10.1161/CIRCINTERVENTIONS.112.000159. Epub 2013 Apr 2.
- Derived from this study: PubMed 23453104Westerhout CM, Pieper KS, James SK, Mahaffey KW, de Werf FV, Califf RM, Granger CB, Armstrong PW. Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Am Heart J. 2013 Mar;165(3):354-62.e2. doi: 10.1016/j.ahj.2012.12.001. Epub 2013 Jan 15.
- Derived from this study: PubMed 23351826Patel MR, Westerhout CM, Granger CB, Brener SJ, Fu Y, Siha H, Kim RJ, Armstrong PW. Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J. 2013 Feb;165(2):226-33. doi: 10.1016/j.ahj.2012.10.028. Epub 2012 Nov 24.
- Derived from this study: PubMed 22814783Truffa AA, Granger CB, White KR, Newby LK, Mehta RH, Hochman JS, Patel MR, Pieper KS, Al-Khalidi HR, Armstrong PW, Lopes RD. Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes. JACC Cardiovasc Interv. 2012 Jul;5(7):769-76. doi: 10.1016/j.jcin.2012.03.018.
- Derived from this study: PubMed 22795281Martel C, Granger CB, Ghitescu M, Stebbins A, Fortier A, Armstrong PW, Bonnefoy A, Theroux P. Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J. 2012 Jul;164(1):43-51. doi: 10.1016/j.ahj.2012.04.007. Epub 2012 Jun 15.
- Derived from this study: PubMed 22589297van Diepen S, Widimsky P, Lopes RD, White KR, Weaver WD, Van de Werf F, Ardissino D, van't Hof AW, Armstrong PW, Granger CB. Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights. Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):437-44. doi: 10.1161/CIRCOUTCOMES.112.965160. Epub 2012 May 15.
- Derived from this study: PubMed 21304097Hudson MP, Armstrong PW, O'Neil WW, Stebbins AL, Weaver WD, Widimsky P, Aylward PE, Ruzyllo W, Holmes D, Mahaffey KW, Granger CB. Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):183-92. doi: 10.1161/CIRCOUTCOMES.110.945311. Epub 2011 Feb 8.
- Derived from this study: PubMed 20501476Huber K, Holmes DR Jr, van 't Hof AW, Montalescot G, Aylward PE, Betriu GA, Widimsky P, Westerhout CM, Granger CB, Armstrong PW. Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. Eur Heart J. 2010 Jul;31(14):1708-16. doi: 10.1093/eurheartj/ehq143. Epub 2010 May 25.
- Derived from this study: PubMed 20435202Alhadramy O, Westerhout CM, Brener SJ, Granger CB, Armstrong PW; APEX AMI Investigators. Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J. 2010 May;159(5):899-904. doi: 10.1016/j.ahj.2010.02.028.
- Derived from this study: PubMed 20129531Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. JACC Cardiovasc Imaging. 2010 Jan;3(1):52-60. doi: 10.1016/j.jcmg.2009.09.014. Epub 2010 Jan 12.
- Derived from this study: PubMed 20089518Trendelenburg M, Theroux P, Stebbins A, Granger C, Armstrong P, Pfisterer M. Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J. 2010 May;31(10):1181-7. doi: 10.1093/eurheartj/ehp597. Epub 2010 Jan 19.
Related trials for Acute Myocardial Infarction
Not yet recruitingObservational study
Elicit Drugs in Myocardial Infarction
Young Patients With Acute Myocardial Infarction
Recruiting
CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes
Coronary Artery Disease, Chest Syndrome
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Recruiting
Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac Patients
Myocardial Infarction, Myocarditis Acute
Enrolling by invitationPhase 3
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
Acute Myocardial Infarction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Thomas G Todaro, MD, JD, FACC study director
Procter and Gamble
349 sites in 17 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Pexelizumab in people with Acute Myocardial Infarction, run by Procter and Gamble at 349 sites in 17 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 349 sites in United States, Germany, Australia, Czechia, Italy and 12 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reduction of all causes of mortality (time frame: day 30). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00091637, which also lists 16 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2023.